Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
55.64
-2.85 (-4.87%)
At close: May 5, 2026, 4:00 PM EDT
55.64
0.00 (0.00%)
After-hours: May 5, 2026, 4:51 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.03 billion as of May 5, 2026. Its market cap has increased by 104.93% in one year.
Market Cap
8.03B
Enterprise Value
6.60B
1-Year Change
104.93%
Ranking
Category
Stock Price
$55.64
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.03B, an increase of 482.17%. That is a compound annual growth rate of 34.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 8.04B | 33.13% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 10.48B |
| BioMarin Pharmaceutical | 10.45B |
| Praxis Precision Medicines | 9.03B |
| ABIVAX Société Anonyme | 8.96B |
| Bio-Techne | 8.61B |
| Cytokinetics | 7.87B |
| Krystal Biotech | 7.83B |
| Nuvalent | 7.79B |